[yoast-breadcrumb]
CTTI Project: Developing Novel Endpoints
Mobile technologies hold enormous promise for clinical research, but uncertainty about how to use the data captured by these devices has slowed progress. CTTI's newly released recommendations and tools aim to change this by providing a pathway for using information gathered from mobile technologies to accelerate the development and evaluation of urgently needed therapies.
Download Press Release (191.89 KB)
[yoast-breadcrumb]
CTTI Project: Recruitment
CTTI has released new recommendations and tools for enhancing the efficiency of clinical trial recruitment that are now available to download. Patient recruitment is a leading challenge in the efficient completion of clinical trials, which can result in wasted resources and delays in bringing new therapies to market. The foundational principle for this new approach is that recruitment planning should be started earlier in the clinical trial development process and continue throughout the implementation.
Download Press Release (168.18 KB)
[yoast-breadcrumb]
CTTI Project: Safety Reporting
Despite legal and ethical mandates for disclosure, results from most clinical trials of medical products are not reported promptly on a registry specifically created to make results of human studies publically available, according to Duke Medicine researchers.
Download Press Release (77.14 KB)
CTTI Project: ABDD Peds Trials
The number of clinical trials enrolling children is far lower than for adults, and the scope of research is also narrower, according to an analysis of public-access data conducted by researchers at Duke University.
Download Press Release (58.76 KB)
[yoast-breadcrumb]
CTTI Project: Patient Engagement
As part of an effort to improve the way clinical trials are conducted, the Clinical Trials Transformation Initiative (CTTI) has formed a 16-member council to engage patient advocates in its mission.
Download Press Release (50.61 KB)
[yoast-breadcrumb]
CTTI Project: State of Clinical Trials
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Download Press Release (57.46 KB)
